ZYDUSLIFE vs MANKIND: Stock Comparison

Head-to-head financial and trading comparison between Zydus Lifesciences Limited (ZYDUSLIFE) and Mankind Pharma Limited (MANKIND) in the Pharmaceuticals & Healthcare sector.

ZYDUSLIFE

NSE: ZYDUSLIFE
Zydus Lifesciences Limited
₹1,145.70
1Y Return: +25.16%
52W High: ₹1,215.00
52W Low: ₹891.90
Annual Volatility: 27.28%
Check ZYDUSLIFE Trade Fees →

MANKIND

NSE: MANKIND
Mankind Pharma Limited
₹2,535.00
1Y Return: +21.93%
52W High: ₹2,617.90
52W Low: ₹2,077.40
Annual Volatility: 30.07%
Check MANKIND Trade Fees →

Key Metrics Comparison Table

MetricZYDUSLIFEMANKINDEdge / Winner
Current Market Price (CMP) ₹1,145.70 ₹2,535.00 —
1-Year Price Return +25.16% +21.93% ZYDUSLIFE (3.23% higher)
52-Week High ₹1,215.00 ₹2,617.90 —
52-Week Low ₹891.90 ₹2,077.40 —
30-Day Annualized Volatility 27.28% 30.07% ZYDUSLIFE (Steadier)
30-Day Average Daily Volume 1,510,992 469,517 ZYDUSLIFE (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between ZYDUSLIFE and MANKIND, which stock gave better returns over the last year?

ZYDUSLIFE has outperformed MANKIND over the past 12 months with a gain of 25.16% compared to 21.93%.

Which stock is less volatile: ZYDUSLIFE or MANKIND?

ZYDUSLIFE demonstrated lower price volatility (27.28% annualized) compared to MANKIND (30.07%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of ZYDUSLIFE vs MANKIND?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are ZYDUSLIFE and MANKIND direct sector competitors?

Yes, both companies operate within the Pharmaceuticals & Healthcare sector in India and are actively tracked as sector peers by institutional and retail market participants.